Long-Term Treatment with Fluvoxamine Decreases Nonmotor Symptoms and Dopamine Depletion in a Postnatal Stress Rat Model of Parkinson’s Disease

Figure 2

Effect of Fluvoxamine on plasma corticosterone levels of nonseparated (NS, NSF) and maternally separated (MS, MSF) rats at PND 76. A two-way ANOVA revealed a significant main effect of stress (, ; NS vs. MS, , Tukey post hoc test) and a significant interaction between stress and Fluvoxamine treatment (, ; ^&MS vs. MSF, , Tukey post hoc test). Data are expressed as (/group).